IFNG and Alzheimer disease: Similarly, after EGb treatment, the decrease in IFN-γ production by VSV-infected PBLs from AD patients was observed—from MedIFN−γ−α;ADPBLs+VSV; before=9.86 pg/mL to MedIFN−γ−α;ADPBLs+VSV; after=2.83 pg/mL.